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Abstract
Background: Carcinoid is an endocrine cell tumor with low-grade atypia, which is generally a low-grade malignant
cancer with a good prognosis. Metastatic renal carcinoid is even rarer than primary carcinoids.
Case presentation: We present our experience of a patient with metastatic renal carcinoid from the
gastrointestinal tract.
Conclusions: The carcinoid tumor of the kidney in our patient, who had a history of liver metastasis from rectal
carcinoid, was considered metastatic based on the pathological findings.
Background
Carcinoid tumor was first detected as multiple tumors
in the ileum by Lubarsch during autopsy more than 100
years ago [1]. The concept of this disease is an endo-
crine cell tumor with low-grade atypia, which is gener-
ally a low-grade malignant cancer with a good
prognosis. About 70% of carcinoid tumors occur in the
gastrointestinal tract, including the rectum, appendix,
stomach, and ileum. The rest of them arise mainly from
neuroendocrine cells in the pancreas, gonads and pul-
monary bronchi, and they rarely occur in the kidney.
Metastatic renal carcinoid is even rarer, with only one
reported case [2]. Here, we present our experience of a
patient with metastatic renal carcinoid with a review of
the literature.
Case presentation
A 56-year-old man underwent resection of a rectal car-
cinoid twelve years ago, and subsequently underwent
resection of liver metastases of rectal carcinoid twice,
twelve and ten years ago. Two years ago, he was found
to have a 3-cm mass in the left kidney on ultrasonogra-
phy during a general checkup, and attended our depart-
ment. Results of routine blood chemical analysis and
urinalysis were unremarkable.
Ultrasonography revealed a 3-cm relatively well-
defined mass in the lower pole of the left kidney, and
the interior of the mass was low echoic, unclear of
margin, and hypovascular. Contrast-enhanced abdominal
CT demonstrated a poorly enhanced, well-defined mass
at the above-mentioned site in both the arterial and
venous phases (Figure 1A). MRI showed a well-defined
mass containing irregular high-signal-intensity areas on
T1-weighted images and relatively low-signal-intensity
areas on T2-weighted images. Bone scintigraphy did not
reveal any obvious bone metastases.
Since these findings did not rule out malignancy, left
renal cell carcinoma T1aN0M0 was diagnosed. Accord-
ing to the patient’s strong wishes, left nephrectomy was
performed laparoscopically through the retroperitoneal
approach. Examination of the resected specimen revealed
a 2 × 2 × 3 cm well-defined, solid tumor with a white
capsule in the inferior pole of the kidney (Figure 1B).
Histopathologically, hematoxylin and eosin staining
revealed cells uniformly arranged in a trabecular or funi-
cular pattern. The cytoplasm was ill-defined and showed
eosinophilic staining. The nucleus was ovoid to short
fusiform, with no obvious mitoses. The tissue was partly
necrotic. Immunostaining was positive for synaptophysin
and chromogranin A, and negative for p53 (Figure 2A,
B, C). These findings were consistent with those of
hematoxylin and eosin staining of specimens of the rec-
tum and liver reported by the patient’s former physician.
Electron microscopy was not performed. Based on the
pathological findings and the history of liver metastasis
from rectal carcinoid, we diagnosed metastatic renal
carcinoid.
Postoperatively, blood tests, urinalysis, imaging, gas-
trointestinal endoscopy and other examinations showed
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two years.
Discussion
Carcinoid tumors are generally considered to arise from
neuroendocrine cells, and secrete different substances
depending on their primary site. Such tumors character-
istically secrete serotonin, although some of them are
inactive. Accordingly, urinary secretion of 5-hydroxyin-
dole acetic acid (5-HIAA), a metabolite of serotonin,
increases. Other hormones and biochemical substances
secreted from carcinoid tumors include corticotropin,
histamine, dopamine, substance P, neurotensin, prosta-
glandins and kallikrein. Secretion of these vasoactive
substances, including serotonin, may cause symptoms of
palpitations, hot flushes, wheezing, diarrhea, and skin
flushing, as well as carcinoid syndrome such as right-
sided valvular disease. Since serotonin and other similar
substances are metabolized mainly in the liver, carcinoid
syndrome is observed only when such substances flow
directly into the systemic circulation from metastatic
lesions in the liver, lung, gonads etc., without involving
the liver. From the perspective of a histogenetic path-
way, carcinoid is a benign tumor originating from
epithelial stem cells, and highly malignant carcinoids are
referred to as endocrine cell carcinoma. For differentia-
tion of malignancy, immunostaining for p53 is useful.
Nishikura et al. conducted a study in a total of
98 patients with gastric endocrine cell carcinoma or car-
cinoid tumor, and reported that patients with carcinoid
tumor did not have any p53 protein overexpression or
genetic mutation [3].
Moyana et al. investigated the association between dif-
ferentiation of gastrointestinal carcinoid and MIB-1,
p53, and bcl-2 in 58 patients, and reported that MIB-1
and p53 could be prognostic factors [4].
Nearly 100 cases of primary renal carcinoid have been
reported since Resnick et al. reported the first case in
1966 [5]. There has been no established view on factors
involved in the occurrence of renal carcinoid, but the
following mechanisms have been hypothesized: 1) Neu-
roendocrine cells that do not normally exist in the kid-
ney undergo neoplastic changes, 2) stem cells induce
neuroendocrine differentiation, 3) the transitional
epithelium of the renal pelvis develops intestinal meta-
plasia, and renal carcinoid originates from neuroendo-
crine cells present at this site, and 4) renal carcinoid
arises from the migration of intestinal or bronchial
epithelium into the kidney [6].
Romero et al. reviewed 56 case reports of renal carci-
noid [7]. The median age of the patients was 49 years,
with no sex difference. Horseshoe kidney was present in
17.8% of patients, and renal carcinoid was incidentally
diagnosed in 28.6% of patients. The most common symp-
tom was abdominal pain, and carcinoid syndrome was
seen in 12.7% of patients. Many (73.6%) of the tumors
were 4 cm or more in diameter, and as many as 45.6% of
the patients already had metastasis at initial diagnosis.
Although lymph node metastases were detected in as
many as 47% of patients, renal carcinoid was found to
have a relatively good outcome, with a mean disease-free
interval of 43 months during follow-up. However, some
of the patients with metastasis to solid organs such as the
liver, contralateral kidney or bone had a poor outcome
and died within a few months. Krishnan et al.r e p o r t e d
that renal carcinoid often complicates horseshoe kidney,
polycystic kidney or renal teratomata [8]. In particular,
h o r s e s h o ek i d n e yi sk n o w nt ob ea s s o c i a t e dw i t ha6 2 %
higher risk of carcinoid; such carcinoids tend to arise
from a solid teratoma, and are considered to have a bet-
ter outcome than those complicating other underlying
renal diseases. Renal carcinoid is mostly detected inci-
dentally by imaging, and is rarely accompanied by symp-
toms such as flank pain, hematuria or a palpable mass.
Imaging findings of renal carcinoid are nonspecific, while
angiography often reveals a hypovascular mass, and ultra-
sonography, CT, and MRI visualize a well-defined mass.
This disease should be differentiated most importantly
from renal cell carcinoma, as well as from benign renal
tumors including oncocytoma, angiomyolipoma or mala-
coplakia. As in cases of other carcinoid, surgical resection
Figure 1 CT images. (A): A 3 cm poorly enhanced, well-defined
mass was observed in the inferior pole of the left kidney on CT. (B):
A 2 × 2 × 3 cm well-defined, solid tumor with a white capsule was
detected in the inferior pole of the left kidney at operation. Inside
the mass, hematoma and necrotic tissue were partly observed.
Neither obvious enlargement of lymph nodes nor metastasis to
intraperitoneal organs was seen.
Figure 2 Histopathological examination. Immunostaining was
positive for synaptophysin (A) and chromogranin A (B), and
negative for p53 (C).
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shi et al. reported the first case of renal carcinoid treated
by laparoscopic partial nephrectomy [9].
To our knowledge, there has been only one reported
case of metastatic renal carcinoid (metastasis from the
lung to the right kidney) by Tal e tal[2]. This patient
was a 64-year-old woman who underwent resection of a
pulmonary carcinoid and then was incidentally found to
have a renal carcinoid 2 years later during detailed inves-
tigation of a left neck mass. Abdominal CT revealed a
hepatic mass and a renal mass measuring 5 × 8 cm. The
renal mass had invaded the renal pelvis and vein. The
patient did not have any other noteworthy abnormalities
or signs of carcinoid syndrome. She underwent partial
hepatectomy and right nephrectomy. Microscopically,
immunostaining was positive for chromogranin and neu-
ron-specific enolase. Indium-111 octreotide scan was
performed and showed positivity along with the left neck
mass. The somatostatin analog octreotide, which is
expressed in 80% or more of carcinoid tumors, was
found to be useful for diagnostic staging. But it’s impossi-
ble to use octeride at our institution.
In this case, we should choose and recommend
laparoscopic partial nephrectomy even if the patient had
strong wish to laparosopic radical nephrectomy.
Because, Simmons et al. reported that in appropriate
patients with Stage T1b-T3 tumor >4 cm, laproscopic
partial nephrectomy provides equivalent oncologic effi-
cacy and superior renal functional outcomes compared
with laparoscopic radical nephrectomy [10].
Conclusions
The carcinoid tumor of the kidney in our patient, who
had a history of liver metastasis from rectal carcinoid,
was considered metastatic based on the pathological
findings. In view of the tumor being p53-negative and
no apparent recurrence to date, he seemed to have a
good prognosis.
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